Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: "Assembly Democrats want to guarantee access to abortion for New York state residents if the Supreme Court overturns the landmark Roe v. Wade decision. A bill, commonly referred to as the Reproductive Health Act, would change state law to guarantee women the choice to have or refuse an abortion or contraception if the Supreme Court reverses Roe v. Wade. Different versions of the bill have been introduced for at least seven years in the Legislature. This year’s debate over the measure included tough questions to the bill’s sponsor, Assemblymember Deborah J. Glick, from members opposed to the bill. ""So, if a baby is born intact and alive but has not yet taken its first breath, it has no rights?"" Assemblymember Steven F. McLaughlin asked. ""Is that the position you are taking?"" ""New York state law says you are alive when you begin to breathe,"" Glick said. ""That’s not me, that’s just the law."" Is Glick right? Is that the law? State abortion law Glick said her definition comes from the current state law on abortion. The definition is included in the state’s penal law, or criminal code, which defines the crime of abortion, where someone intentionally causes a pregnancy to be terminated without consent or justification. The law says a person, ""when referring to the victim of a homicide, means a human being who has been born and is alive."" So a fetus inside the womb is not considered a person, and therefore does not have rights under state law. That is why someone can legally have an abortion after being pregnant for 24 weeks to preserve the life of the mother. State health law State health law goes a step further in defining when someone is considered born. Under Public Health Law, live birth is defined as ""the complete expulsion or extraction from its mother of a product of conception, irrespective of the duration of pregnancy, which, after such separation, breathes or shows any other evidence of life such as beating of the heart, pulsation of the umbilical cord, or definite movement of voluntary muscles, whether or not the umbilical cord has been cut or the placenta is attached; each product of such a birth is considered live born."" It is up to a medical professional to determine if there is evidence of life in the infant. If the medical professional finds evidence, it is legally considered the birth of a person. ""The reality is that if they are born and alive they are a person and have full rights,"" Glick said in a phone interview. ""And that is the determination of a medical person at the time."" Our ruling Glick said during an Assembly debate that ""New York state law says you are alive when you begin to breathe."" State law says a person has been born alive when the fetus has exited the woman’s body and shows signs of life. The law specifically mentions breathing as one of the signs. But the law also mentions other evidence of life, such as a beating heart.s ."
[EX A]: New York state law says you are alive when you begin to breathe.

[EX Q]: While governments in at least 20 other states obtained more than 30 million doses of the drug through donations from the federal reserve or private companies, Oklahoma and Utah instead bought them from private pharmaceutical companies. Top officials in both states chalked up the decisions to “the fog of war.”  Oklahoma Gov. Kevin Stitt on Tuesday defended the state’s $2 million purchase, saying the drug was showing some promise. His health secretary attributed buying the 1.2 million hydroxychloroquine pills to something that happens in the “fog of war.”  Utah Gov. Gary Herbert at first defended the state’s $800,000 purchase of 20,000 packets of hydroxychloroquine compounded with zinc, but has since ordered an investigation of a no-bid contract with a local company that had been promoting the drugs. Herbert, a Republican, also canceled an additional plan to spend $8 million more to buy 200,000 additional treatments from the same company. A left-leaning nonprofit group in Utah filed a price gouging complaint Tuesday with state regulators, arguing the $40 per pack drug was grossly overpriced. Oklahoma’s attorney general requested an investigative audit on Tuesday of its Department of Health over spending and warned the agency about retaliating against employees who report wrongful government activities under the state’s Whistleblower Act. A spokesman for Attorney General Mike Hunter declined to comment on whether the request was related to the $2 million spent on the drug. Doctors can already prescribe the malaria drug to patients with COVID-19, a practice known as off-label prescribing, and many do. But the U.S. Food and Drug Administration on Friday warned doctors against prescribing hydroxychloroquine for treating the coronavirus outside of hospitals or research settings because of reports of serious side effects, including irregular heart rhythms and death among patients. Preliminary results from a recent study done on coronavirus patients at U.S. veterans hospitals showed no benefit, casting more doubt on the drug’s efficacy during the pandemic. Those were the latest admonitions against the drug that Trump has regularly promoted in public appearances, touting its potential despite his own health advisors telling him it is unproven. Oklahoma acquired 1.2 million pills, or about 100,000 doses, on April 4 from FFF Enterprises, a California-based medical supply wholesaler, according to the Oklahoma State Department of Health. Oklahoma state Rep. Melissa Provenzano, a Democrat from Tulsa, said the state’s purchase shows that Gov. Stitt’s actions don’t follow his claim that he relies on data to drive his decisions. “Two million dollars is a lot of money to waste, especially when we have unemployment claims approved yet going unpaid, health care professionals without proper protective equipment, and diagnosed cases and deaths continuing to rise,” Provenzano said. Stitt, a first-term Republican, said hydroxychloroquine was showing some promise as a treatment in early March, and he didn’t want Oklahoma to miss out on an opportunity to acquire it. “Now there’s some evidence the chloroquine may not be as effective, but I was being proactive to try and protect Oklahomans,” Stitt said Tuesday when asked about the purchase. “That’s always going to be my first instinct, to get the equipment and things we need that I’m seeing in the future would help Oklahomans.” Oklahoma’s Secretary of Health Jerome Loughridge said several physicians, including some in Oklahoma, were previously optimistic about the drug’s promise in treating COVID-19. He added that the drug is also useful for treating lupus and some other auto-immune diseases, so the state’s supply “will not have gone to waste.” “When we were battling sort of the fog of war at that point, we certainly acquired it on the potential that it would have utility,” Loughridge said. Jeff Burton, a former adjutant general of the Utah National Guard chosen to lead the state health department’s coronavirus task force, offered a similar explanation for why the state made its purchase. He said the state never received the pills and is trying to get its money back. “I chalk it up to fog of war,” Burton told the state’s pharmacy board. “There was a lot going on. It’s easy to judge it from (an) easy chair.. . . Since then we’ve decided that was not a wise purchase.”  Doctors in Oklahoma have been using the drug to treat patients with COVID-19, often in conjunction with a second drug, azithromiocin, but the results “just are not that promising,” said Dr. Douglas Drevets, chief of infectious diseases at University of Oklahoma Medicine. FFF Enterprises said it’s the company’s policy not to comment on transactions with customers. Utah gave a local company called Meds in Motion the $800,000 contract without taking bids from other companies under emergency procurement rules, said Christopher Hughes, director of Utah’s division of purchasing. State officials haven’t explained why they didn’t seek to get the drugs for free. The Federal Emergency Management Agency said Saturday it has sent out 28.6 million tablets of hydroxychloroquine sulfate free of cost to states around the country. Several states including New York, Connecticut and Texas received donations of the medication from a private company based in New Jersey called Amneal Pharmaceutical, according to information compiled by The Associated Press. Utah taxpayers deserve to know what happened to allow a purchase that seems like a company taking advantage of the early, chaotic days of the pandemic, said Chase Thomas, executive director of the group called Alliance for a Better Utah that submitted the price gouging complaint. The complaint alleges Utah paid at least double the common price for the medication. “Whether they were buying drugs we didn’t need or paying too much for it when they could have gotten them for free, there just needed to be a lot more thought going into this,” Thomas said. Meds in Motion didn’t answer an email seeking comment about the allegations. Herbert declined to provide an update Tuesday about the investigation of the purchase. He said Friday the state’s legal counsel would aim to find out what, how and why it happened. He said he believed state officials acted in good faith as they scrambled to slow the spread of coronavirus, but acknowledged a mistake may have been made. “I have some questions about how it came about,” Herbert said Friday. “Bottom line is, we’re not purchasing any more of this drug.”  ___ McCombs and Whitehurst reported from Salt Lake City.
[EX A]: Oklahoma, Utah face scrutiny over malaria drug purchases.

[EX Q]: Engineers at the Mint created the visors after finding a basic design online and developing medically approved prototypes within 48 hours at their production site in Wales. The first visors are already in use at a hospital in Wales and mass production will start on Saturday morning, with several hundred coming on the first day and increasing numbers after that. The Mint says it can produce thousands of visors per day if it can get enough parts and is now appealing to manufacturers across the UK to help it source enough clear plastic, which is currently in short supply. The simple design comprises a clear plastic shield which covers the worker’s face, held in place by a piece of elastic. Britain’s publicly funded national health service, the NHS, has received much public support during the coronavirus outbreak, with government health authorities adopting the slogan “Stay Home, Protect The NHS, Save Lives”. People all over the country took to their balconies and doorsteps on Thursday evening to applaud health workers who are battling the spread of the coronavirus. “My sister works for the NHS and it really focuses your mind on the challenges they are facing,” said Leighton John, director of operations at the Royal Mint. “We set our engineers the task of developing essential medical equipment which could be easily made on site – within seven hours they’d created a medical visor, and within 48 hours it was approved for mass manufacture,” John said. As the virus sweeps the country, the Mint is the latest in a number of companies taking on new operations as part of a nationwide effort to support the NHS. Vacuum cleaner company Dyson was recruited to supply hospitals with 10,000 medical ventilators designed at breakneck speed ahead of an expected surge of cases, and outsourcer Capita announced on Friday it was working with the government to provide coronavirus testing sites.
[EX A]:
UK's Royal Mint making coronavirus protective gear for health staff.